765 results on '"Sollinger H"'
Search Results
52. Pancreas Retransplantation: A 10-Year Report of International Pancreas Transplant Registry Outcomes.
53. Impact of ureteral stricture and treatment choice on long‐term graft survival in kidney transplantation
54. Tacrolimus in pancreas transplantation: A multicenter analysis
55. Early Urinary Complications in Renal Transplantation: A Potential Risk Factor for Allograft Rejection
56. UROLOGICAL COMPLICATIONS AND ENTERIC CONVERSION AFTER PANCREAS TRANSPLANTATION WITH BLADDER DRAINAGE
57. DONOR SMALL VESSEL DISEASE AND INTERSTITIAL FIBROSIS CORRELATE WITH SHORT TERM KIDNEY ALLOGRAFT DYSFUNCTION
58. SELENIUM SUPPLEMENTATION PREVENTS KIDNEY FIBROGENESIS INDEPENDENTLY FROM ITS EFFECTS ON SELENIUM BINDING PROTEIN-1
59. A TRIAL OF MYCOPHENOLATE MONOTHERAPY IN HLA IDENTICAL SIBLING RENAL TRANSPLANTATION
60. Simultaneous pancreas — kidney transplantation: Recent experience at the University of Wisconsin
61. MYFORTIC VS. CELLCEPT: A LARGE, SINGLE-CENTER COMPARISON
62. OUTCOMES OF SOLITARY PANCREAS TRANSPLANTS RELATED TO INDUCTION THERAPY AND TRANSPLANT TYPE
63. POST-OPERATIVE TISSUE REGENERATION IN RENAL TRANSPLANTATION: COMPARABLE OUTCOME WITH EVEROLIMUS OR MMF
64. HEPATOCYTE BASED INSULIN GENE THERAPY
65. ANTIBODY-MEDIATED REJECTION OF THE KIDNEY AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION (SPKT): ALEMTUZUMAB IS NOT SUPERIOR TO BASILIXIMAB AS INDUCTION TREATMENT
66. ANTIBODY-MEDIATED REJECTION IN RENAL ALLOGRAFT RECIPIENTS TREATED WITH ALEMTUZUMAB INDUCTION
67. ACUTE ANTIBODY-MEDIATED REJECTION (AMR) OF THE KIDNEY ALLOGRAFT: IS THERE ANY DIFFERENCE IN OUTCOMES IN FOCAL VS DIFFUSE C4D STAINING CASES?
68. PREDICTORS OF NEW ONSET DIABETES AFTER PANCREAS TRANSPLANT
69. C4D POSITIVE INTERACINAR CAPILLARIES CORRELATES WITH DONOR-SEPCIFIC ANTIBODY MEDIATED REJECTION IN PANCREAS ALLOGRAFTS CORRE
70. HISTOPATHOLOGIC PARAMETERS ASSOCIATED WITH ACUTE ANTIBODY MEDIATED REJECTION CORRELATE BETTER WITH THE DEVELOPMENT OF CHRONIC ALLOGRAFT INJURY COMPARED TO PARAMETERS ASSOCIATED TO ACUTE CELLULAR REJECTION
71. Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance
72. Immunoalteration of murine thyroid gland in UW solution at hypothermia
73. Does organ culture prolong the survival of thyroid allografts in the dog?
74. A NEW MODIFIED TECHNIQUE OF URETEROURETEROSTOMY IN RAT KIDNEY TRANSPLANTATION
75. ALEMTUZUMAB IMPROVES OUTCOMES IN RENAL TRANSPLANTATION
76. SYSTEMIC PLASMID DNA GENE TRANSFER INTO DIABETIC MICE CAUSES GLUCOSE-DEPENDENT HEPATIC INSULIN EXPRESSION
77. Donation after Cardiac Death A viable method to increase organ availability for Simultaneous Pancreas-Kidney Transplantation.
78. The Impact of Pancreas Transplantation on Mortality and Kidney Allograft Survival: Retransplantation Compared with Primary Transplants
79. EXPERIENCE WITH 146 ENTERIC CONVERSIONS (EC): INDICATIONS AND OUTCOMES
80. Superior Long Term Results of Kidney Transplants from Simultaneous Pancreas-Kidney Transplantation (SPK) from Pediatric Donors Compared to Diabetic recipients of Living Related Kidney Transplant.
81. Gibt es klinisch eine spenderspezifische Toleranz und ist sie messbar?
82. 245. Maschenlappen und Xenotransplantate zur Deckung ausgedehnter Verbrennungen
83. Is tolerance a clinical reality?
84. THE IMPACT OF HYPOALBUMINEMIA IN KIDNEY-PANCREAS TRANSPLANT RECIPIENTS1
85. The Effect of Tolerance to Noninherited Maternal HLA Antigens on the Survival of Renal Transplants From Sibling Donors
86. MULTICENTER RETROSPECTIVE ANALYSIS OF SIMULTANEOUS KIDNEY PANCREAS TRANSPLANT RECIPIENTS RECEIVING DACLIZUMAB INDUCTION
87. IS SHARING FOR SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTS JUSTIFIED?
88. MIXED LYMPHOCYTE ISLET CELL CULTURE ANALYSIS OF CD45-DEPLETED HUMAN FETAL PANCREAS.
89. INCREASING EXPECTED LIFESPAN: THE IMPACT OF KIDNEY-PANCREAS TRANSPLANTATION
90. RARE CIRCULATING DONOR CELLS INHIBIT ANTI-DONOR CYTOLYTIC ACTIVITY DURING PERIPHERAL TOLERANCE
91. FK506 AND MYCOPHENOLATE MOFETIL USE IN PEDIATRIC RENAL TRANSPLANTATION
92. CHANGING DONOR AND RECIPIENT DEMOGRAPHICS AFFECTS LONG-TERM RENAL ALLOGRAFT OUTCOME
93. INTRAGRAFT HYPERTENSION AND METALLOPROTEINASE GENE EXPRESSION: MODULATORS OF GRAFT FUNCTION
94. USING THE FRAMINGHAM DATABASE TO PREDICT CORONARY HEART DISEASE (CHD) EVENTS IN RENAL TRANSPLANT PATIENTS
95. INTRAVENOUS MYCOPHENOLATE MOFETIL (MMF): SAFETY, TOLERABILITY, AND PHARMACOKINETICS
96. A SURVEY OF MALE SEXUAL FUNCTION FOLLOWING PANCREAS TRANSPLANTATION
97. PERIPHERAL TOLERANCE TO NON-INHERITED MATERNAL HLA ANTIGENS: LOSS OF "DIRECT PATHWAY" T CELL RECEPTOR mRNA SIGNALS DURING BREAKDOWN OF TOLERANCE IN A RENAL TRANSPLANT RECIPIENT
98. STABILITY OF THE TOLERANCE PHENOTYPE AFTER WITHDRAWAL OF IMMUNOSUPPRESSIVE DRUG THERAPY: INFLUENCE OF LOCAL AND GENETIC FACTORS INFLUENCING TNFα AND TGFβ EXPRESSION
99. A MULTICENTER, RANDOMIZED TRIAL OF SIMULECT® WITH EARLY NEORAL® VS. ATGAM® WITH DELAYED NEORAL® IN RENAL TRANSPLANTATION. A 6-MONTH INTERIM ANALYSIS.
100. BONE MASS REMAINS STABLE IN SIMULTANEOUS PANCREAS-KIDNEY (SPK) RECIPIENTS IN THE FIRST YEAR POST-TRANSPLANT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.